Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 97 Results

Title
Intervention Indication Therapeutic Area Year Actions
Concizumab for treating haemophilia A and haemophilia B Concizumab (NN-7415; mAb-2021; NNC-0172-0000-2021; NNC-0172-2021; NNC-172-2021) Haemophilia A , Haemophilia B Haematology 2022 View  |  Download
Crovalimab for treatment of paroxysmal nocturnal haemoglobinuria Crovalimab Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2022 View  |  Download
Dabrafenib with trametinib for treating paediatric BRAF V600 mutated high-grade or low-grade glioma Dabrafenib (Tafinlar; GSK2118436; dabrafenib mesilate) , Trametinib (Mekinist; TMT212; GSK-1120212B; GSK1120212; JTP-74057; trametinib dimethyl sulfoxide) Glioma Neurological Cancer 2022 View  |  Download
Danicopan with eculizumab or ravulizumab for treating paroxysmal nocturnal haemoglobinuria Danicopan (ACH-0144471; ACH-4471; ALXN2040) , Ravulizumab (ALXN1210; Ultomiris) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2022 View  |  Download
Dersimelagon for previously untreated erythropoietic protoporphyria and X-linked protoporphyria Dersimelagon Erythropoietic protoporphyria , X-linked protoporphyria Dermatology , Haematology 2022 View  |  Download
Dexmedetomidine film for agitation associated with bipolar disorder Dexmedetomidine Bipolar disorder Mental and Behavioural Health 2022 View  |  Download
Dexmedetomidine film for agitation in schizophrenia Dexmedetomidine Schizophrenia Mental and Behavioural Health 2022 View  |  Download
Dupilumab for treating eosinophilic oesophagitis in people aged 12 years and older Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Eosinophilic oesophagitis Gastroenterology , Immunology 2022 View  |  Download
Durvalumab add-on therapy for previously untreated locally advanced cervical cancer Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Cervical cancer Female Reproductive Cancer 2022 View  |  Download
Durvalumab for limited stage small-cell lung cancer after
1 therapy
Durvalumab (Imfinzi; MEDI4736; MEDI-4736; MEDI 4736) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications